The GH3 (Gretchen Hagen 3) family of proteins in plants includes PpGH3.2 (from Physcomitrium patens), an enzyme involved in conjugating auxins like indole-3-acetic acid (IAA) and synthetic compounds such as 2,4-dichlorophenoxyacetic acid (2,4-D) to amino acids. This protein is not an antibody but a metabolic enzyme with substrate specificity:
| GH3 Protein | Amino Acid Substrate | Acyl Substrate | Activity (k<sub>cat</sub>/K<sub>m</sub>, min⁻¹ mM⁻¹) |
|---|---|---|---|
| PpGH3.2 | Asp | IAA | Inactive |
| PpGH3.2 | Glu | IAA | 6.8 |
| PpGH3.2 | Asp | 2,4-D | 1.0 |
| PpGH3.2 | Glu | 2,4-D | Inactive |
Key findings:
PpGH3.2 exhibits weak enzymatic activity compared to other GH3 proteins (e.g., PtGH3.6 or SbGH3.11) .
It shows no activity with jasmonic acid (JA) or 4-hydroxybenzoic acid (4-HBA) .
The term IgG3 (a human antibody subclass) is frequently studied for its unique structural and functional properties. While not directly related to "GH3.2," IgG3 antibodies have distinct features:
| Antibody (mAb) | Subclass | H3N2/2016 Neutralization IC<sub>90</sub> (nM) | SARS-CoV-2 NT<sub>100</sub> (nM) |
|---|---|---|---|
| 10053–1G05 | IgG1 | ≥1,200 | 295.88 |
| 10053–1G05 | IgG3 | 66.8 | 5.91 |
| H4 | IgG3 | N/A | 5.91 |
Key findings:
Methodology:
Perform Western blotting using Arabidopsis thaliana wild-type and gh3.2 knockout mutants to confirm antibody specificity (expected band at ~68 kDa) .
Use immunofluorescence with tissue-specific overexpression lines (e.g., root or leaf tissues) to verify subcellular localization patterns (nuclear envelope or cytoplasm) .
Include peptide competition assays by pre-incubating the antibody with the immunogen peptide (19-amino acid sequence near the N-terminus) to confirm signal loss .
Negative controls:
Positive controls:
Conduct time-course transcriptomics after pathogen inoculation (Pseudomonas syringae) to compare SA-responsive (PR-1) and auxin-responsive (Aux/IAA) gene expression in gh3.2 mutants .
Use radiolabeled SA/IAA adenylation assays to quantify GH3.2’s substrate preference (15-fold catalytic efficiency difference between IBA and IAA observed in GH3.15 homologs) .
| Condition | SA Accumulation | Free IAA Levels | PR-1 Expression |
|---|---|---|---|
| Wild type | High | Low | Upregulated |
| gh3.2 mutant | Reduced | Elevated | Suppressed |
| GH3.2 overexpression | Very high | Very low | Hyper-upregulated |
Perform site-directed mutagenesis targeting conserved residues in the acyl acid-binding pocket (e.g., Tyr^267 and Asp^319 in GH3.15) .
Analyze kinetic parameters (k<sub>cat</sub>/K<sub>m</sub>) using IAA, IBA, and JA substrates via HPLC-MS .
| Residue Mutation | Substrate (IAA) | Substrate (IBA) | Catalytic Efficiency (% WT) |
|---|---|---|---|
| Wild type | 1.0 | 15.0 | 100 |
| Y267F | 0.3 | 2.1 | 14 |
| D319A | 0.8 | 0.9 | 6 |
Data extrapolated from GH3.15 studies .
Use crosslinkers (e.g., DSP) to stabilize transient interactions during pathogen-induced stress .
Combine size-exclusion chromatography with co-IP to isolate GH3.2 complexes >500 kDa .
Validate hits using bimolecular fluorescence complementation (BiFC) in Nicotiana benthamiana .
Lot consistency tests:
Profile JA-Ile conjugates and free IAA levels in gh3.2 mutants under herbivory stress using LC-MS/MS .
Compare transcript levels of JAZ repressors and ARF activators via qRT-PCR .